Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)
Clinical trial NCT03857854 · UNKNOWN
Trial details
- NCT number
- NCT03857854
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-05
- Primary completion
- 2021-02-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.